促炎细胞因子
TLR4型
炎症
脂多糖
免疫学
转录因子
发病机制
医学
生物
基因
生物化学
作者
Urmila Maitra,Hui Deng,Trevor Glaros,Bianca Baker,Daniel G. S. Capelluto,Zihai Li,Liwu Li
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2012-06-17
卷期号:189 (2): 1014-1023
被引量:145
标识
DOI:10.4049/jimmunol.1200857
摘要
Low-dose endotoxemia is prevalent in humans with adverse health conditions, and it correlates with the pathogenesis of chronic inflammatory diseases such as atherosclerosis, diabetes, and neurologic inflammation. However, the underlying molecular mechanisms are poorly understood. In this study, we demonstrate that subclinical low-dose LPS skews macrophages into a mild proinflammatory state, through cell surface TLR4, IL-1R-associated kinase-1, and the Toll-interacting protein. Unlike high-dose LPS, low-dose LPS does not induce robust activation of NF-κB, MAPKs, PI3K, or anti-inflammatory mediators. Instead, low-dose LPS induces activating transcription factor 2 through Toll-interacting protein-mediated generation of mitochondrial reactive oxygen species, allowing mild induction of proinflammatory mediators. Low-dose LPS also suppresses PI3K and related negative regulators of inflammatory genes. Our data reveal novel mechanisms responsible for skewed and persistent low-grade inflammation, a cardinal feature of chronic inflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI